The Extended Brief
Predicting Your Health Arc
Brief by The AI News AI newsroom · Aug 4, 2026, 12:44 PM EDT edition
Original reporting by Ground Truths (Eric Topol) — Eric Topol · published Aug 4, 2026, 11:54 AM EDT
A new AI model predicts individual disease risk far more accurately than standard clinical calculators, potentially enabling earlier, personalized interventions.
Key points
- ALADYNOULLI predicted 10-year coronary artery disease risk with an AUC of 0.89 versus 0.68 for the pooled cohort equation.
- The study analyzed 683,000 individuals across three cohorts with up to 52 years of follow-up.
- The model integrates electronic medical records and 36 polygenic risk scores.
- It uses 21 latent disease signatures and a Gaussian process to dynamically update risk.
- The same disease phenotype can link to different genomic pathway underpinnings, enabling personalized treatment predictions.
The data
Higher AUC indicates better discrimination.
Numbers from the original article, machine-verified against its text
From the source
“An AI model was developed and validated called ALADYNOULLI, with each individual represented latent disease signatures (N=21), mathematically and biologically driven.”
“Using a Gaussian process, the risk continually shifts like a GPS navigation when you make a wrong turn and you are re-routed.”
“the same disease phenotype can link to different genomic pathway underpinnings.”
“This biological pattern could also be used to detect likely medication failure (such as SSRI treatment for depression) and predict rare diseases.”
Practical applications
- Evaluate ALADYNOULLI's latent disease signatures against your own patient cohort to assess personalized risk prediction.
- Incorporate dynamic Gaussian process models into clinical decision support systems to update risk as new data arrives.
- Test the model's genomic signature approach for predicting medication response in depression or other conditions.
- Use inverse probability weighting techniques to address selection bias in longitudinal health datasets.
Who should care
Physician-scientists, clinical AI developers, and health system data teams seeking more accurate, dynamic patient risk stratification tools.
Context
Polygenic risk scores aggregate the effects of many genetic variants to estimate disease susceptibility. The pooled cohort equation is a standard tool for estimating 10-year cardiovascular risk. Gaussian processes are a flexible Bayesian method for modeling trajectories over time.
What to watch
- A prospective clinical trial validating ALADYNOULLI's predictions against real-world outcomes.
- Publication of the model's performance on rare disease prediction in a separate cohort.
Editorial score 3.8 / 5 · significance 4.0 · novelty 4.0 · edge 3.0 · perspective 4.0
Desks: Biotech · Research · Tags: biotech, research
Evidence basis: Reviewed from the article's full text
This brief was written by The AI News AI newsroom in its own words after two independent AI reviewers voted the story worth reading. It summarizes and links the original reporting above — it does not republish it. See the methodology or the corrections ledger.